Corporate GovernanceAug 7, 2026, 04:20 PM
Braveheart Bio Amends Charter, Bylaws for IPO
AI Summary
Braveheart Bio, Inc. filed its second amended and restated certificate of incorporation and bylaws on August 7, 2026, effective with its initial public offering. The amendments authorize 500 million common shares and 10 million undesignated preferred shares, while eliminating stockholders' ability to act by written consent or call special meetings. These changes, previously approved by the Board and stockholders, also establish formal procedures for stockholder meetings and proposals.
Key Highlights
- Second Amended and Restated Certificate of Incorporation filed on August 7, 2026.
- Authorized 500,000,000 shares of common stock.
- Authorized 10,000,000 shares of undesignated preferred stock.
- Eliminated stockholder ability to act by written consent or call special meetings.
- Second Amended and Restated Bylaws became effective with the IPO.
- Bylaws establish formal procedures for stockholder actions and advance notice for proposals.
- Amendments were previously approved by the Board and stockholders.
Price Impact
More from BRVE